147 related articles for article (PubMed ID: 14993029)
41. [Photodynamic therapy of centrally located early-stage lung cancer].
Furuse K
Gan To Kagaku Ryoho; 1996 Jan; 23(1):27-30. PubMed ID: 8546465
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience.
Nseyo UO; DeHaven J; Dougherty TJ; Potter WR; Merrill DL; Lundahl SL; Lamm DL
J Clin Laser Med Surg; 1998 Feb; 16(1):61-8. PubMed ID: 9728133
[TBL] [Abstract][Full Text] [Related]
43. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
[TBL] [Abstract][Full Text] [Related]
44. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
45. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors.
Schmidt MH; Meyer GA; Reichert KW; Cheng J; Krouwer HG; Ozker K; Whelan HT
J Neurooncol; 2004; 67(1-2):201-7. PubMed ID: 15072468
[TBL] [Abstract][Full Text] [Related]
47. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
Goetz C; Hasan A; Stummer W; Heimann A; Kempski O
Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
[TBL] [Abstract][Full Text] [Related]
48. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors.
Hendren SK; Hahn SM; Spitz FR; Bauer TW; Rubin SC; Zhu T; Glatstein E; Fraker DL
Ann Surg Oncol; 2001; 8(1):65-71. PubMed ID: 11206227
[TBL] [Abstract][Full Text] [Related]
49. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Minashi K; Onozawa M; Nihei K; Ishikura S; Kaneko K; Ohtsu A
Endoscopy; 2011 Aug; 43(8):657-63. PubMed ID: 21623555
[TBL] [Abstract][Full Text] [Related]
50. Photodynamic therapy for facial squamous cell carcinoma in cats using Photofrin.
Chang CJ; Lai YL; Wong CJ
Changgeng Yi Xue Za Zhi; 1998 Mar; 21(1):13-9. PubMed ID: 9607259
[TBL] [Abstract][Full Text] [Related]
51. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
[TBL] [Abstract][Full Text] [Related]
52. Photodynamic therapy for the treatment of basal cell carcinoma.
Wilson BD; Mang TS; Stoll H; Jones C; Cooper M; Dougherty TJ
Arch Dermatol; 1992 Dec; 128(12):1597-601. PubMed ID: 1456752
[TBL] [Abstract][Full Text] [Related]
53. Laser dosimetry studies in the prostate.
Chen Q; Hetzel FW
J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
[TBL] [Abstract][Full Text] [Related]
54. Photodynamic therapy in patients with head and neck squamous cell carcinoma.
Hosokawa S; Takebayashi S; Takahashi G; Okamura J; Mineta H
Lasers Surg Med; 2018 Jul; 50(5):420-426. PubMed ID: 29399863
[TBL] [Abstract][Full Text] [Related]
55. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis.
Hahn SM; Fraker DL; Mick R; Metz J; Busch TM; Smith D; Zhu T; Rodriguez C; Dimofte A; Spitz F; Putt M; Rubin SC; Menon C; Wang HW; Shin D; Yodh A; Glatstein E
Clin Cancer Res; 2006 Apr; 12(8):2517-25. PubMed ID: 16638861
[TBL] [Abstract][Full Text] [Related]
56. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC
J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
[TBL] [Abstract][Full Text] [Related]
57. Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells.
Saczko J; Choromańska A; Rembiałkowska N; Dubińska-Magiera M; Bednarz-Misa I; Bar J; Marcinkowska A; Kulbacka J
Biomed Pharmacother; 2015 Apr; 71():30-6. PubMed ID: 25960212
[TBL] [Abstract][Full Text] [Related]
58. Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation.
van Staveren HJ; Beek JF; Ramaekers JW; Keijzer M; Star WM
Phys Med Biol; 1994 Jun; 39(6):947-59. PubMed ID: 15551572
[TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study.
Mlkvy P; Messmann H; Debinski H; Regula J; Conio M; MacRobert A; Spigelman A; Phillips R; Bown SG
Eur J Cancer; 1995; 31A(7-8):1160-5. PubMed ID: 7577013
[TBL] [Abstract][Full Text] [Related]
60. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
